Evidence map›Paper›PMID 20058056›Full record

ArticleMolecular and cellular biochemistry2010

Aggregation of spectrin and PKCtheta is an early hallmark of fludarabine/mitoxantrone/dexamethasone-induced apoptosis in Jurkat T and HL60 cells.

Patrycja M Dubielecka, Michał Grzybek, Adam Kolondra, Bozena Jaźwiec, Anna Draga, Paulina Aleksandrowicz, Monika Kołodziejczyk, Anna Serwotka, Barbara Dolińska-Krajewska, Jerzy Warchoł and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Role of Nonerythroid SpectrinJournal of oncology · 2019
    Review
  6. Article
  7. Article
  8. The Novel PKCθ from Benchtop to Clinic.Journal of immunology research · 2015
    Review
  9. Review
  10. Spectrin-based skeleton as an actor in cell signaling.Cellular and molecular life sciences : CMLS · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Patrycja M DubieleckaLaboratory of Cytobiochemistry, Faculty of Biotechnology, University of Wrocław, S. Przybyszewskiego 63-77, 51-148 Wrocław, Poland. pdubielecka@nybloodcenter.org
Michał Grzybek
Adam Kolondra
Bozena Jaźwiec
Anna Draga
Paulina Aleksandrowicz
Monika Kołodziejczyk
Anna Serwotka
Barbara Dolińska-Krajewska
Jerzy Warchoł
Kazimierz Kuliczkowski
Aleksander F Sikorski
University of Wrocław · PLWroclaw Medical University · PLPoznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been shown that changes in spectrin distribution in early apoptosis preceded changes in membrane asymmetry and phosphatidylserine (PS) exposure. PKCtheta was associated with spectrin during these changes, suggesting a possible role of spectrin/PKCtheta aggregation in regulation of early apoptotic events. Here we dissect this hypothesis using Jurkat T and HL60 cell lines as model systems. Immunofluorescent analysis of alphaIIbetaII spectrin arrangement in Jurkat T and HL60 cell lines revealed the redistribution of spectrin and PKCtheta into a polar aggregate in early apoptosis induced by fludarabine/mitoxantrone/dexamethasone (FND). The appearance of an alphaIIbetaII spectrin fraction that was insoluble in a non-ionic detergent (1% Triton X-100) was observed concomitantly with spectrin aggregation. The changes were observed within 2 h after cell exposure to FND, and preceded PS exposure. The changes seem to be restricted to spectrin and not to other cytoskeletal proteins such as actin or vimentin. In studies of the mechanism of these changes, we found that (i) neither changes in apoptosis regulatory genes (e.g., Bcl-2 family proteins) nor changes in cytoskeleton-associated proteins were detected in gene expression profiling of HL60 cells after the first hour of FND treatment, (ii) caspase-3, -7, -8, and -10 had minor involvement in the early apoptotic rearrangement of spectrin/PKCtheta, and (iii) spectrin aggregation was shown to be partially dependent on PKCtheta activity. Our results indicate that spectrin/PKCtheta aggregate formation is related to an early stage in drug-induced apoptosis and possibly may be regulated by PKCtheta activity. These findings indicate that spectrin/PKCtheta aggregation could be considered as a hallmark of early apoptosis and presents the potential to become a useful diagnostic tool for monitoring efficiency of chemotherapy as early as 24 h after treatment.

Indexed as

ActinsAntineoplastic Combined Chemotherapy ProtocolsApoptosisBlotting, WesternCaspase 3Caspase InhibitorsCytoskeletonDexamethasoneFlow CytometryFluorescent Antibody TechniqueHL-60 CellsHumansIsoenzymesJurkat CellsMitoxantroneOctoxynolActinsCaspase 3Caspase InhibitorsDexamethasonefludarabineIsoenzymesMitoxantroneOctoxynolPRKCQ protein, humanProtein Kinase CProtein Kinase C-thetaRNA, MessengerSpectrinVidarabineVimentin

Identifiers

PMID20058056
OpenAlexW2053567778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.